What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Stroke
- Surgery
His main research concerns Stroke, Internal medicine, Surgery, Randomized controlled trial and Blood pressure.
His studies in Stroke integrate themes in fields like Anesthesia and Clinical trial, Intention-to-treat analysis.
His Internal medicine study integrates concerns from other disciplines, such as Placebo and Cardiology.
His Surgery research is multidisciplinary, relying on both Diabetes mellitus, Observational study and MEDLINE.
His Randomized controlled trial research incorporates themes from Relative risk, Cause of death, Vascular stiffness, Vitamin D and neurology and Physical therapy.
His Blood pressure research includes themes of Meta-analysis, Cognition and Cognitive disorder.
His most cited work include:
- Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 (1793 citations)
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study (1596 citations)
- Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial (951 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Stroke, Internal medicine, Randomized controlled trial, Physical therapy and Emergency medicine.
His Stroke study combines topics in areas such as Emergency medical services, Medical emergency and Surgery.
His research integrates issues of Endocrinology, Gerontology and Cardiology in his study of Internal medicine.
His Randomized controlled trial research focuses on subjects like Placebo, which are linked to Anesthesia.
The Modified Rankin Scale study which covers Odds ratio that intersects with Confidence interval.
His studies deal with areas such as Fibrinolytic agent and Ischaemic stroke as well as Thrombolysis.
He most often published in these fields:
- Stroke (58.35%)
- Internal medicine (27.06%)
- Randomized controlled trial (21.14%)
What were the highlights of his more recent work (between 2016-2021)?
- Stroke (58.35%)
- Randomized controlled trial (21.14%)
- Internal medicine (27.06%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Stroke, Randomized controlled trial, Internal medicine, Emergency medicine and Physical therapy.
His work is dedicated to discovering how Stroke, Medical emergency are connected with Economic evaluation and other disciplines.
His study in Randomized controlled trial is interdisciplinary in nature, drawing from both Odds ratio, Psychological intervention, Cerebral infarction, Adverse effect and Placebo.
His Internal medicine study typically links adjacent topics like Cardiology.
His study looks at the intersection of Emergency medicine and topics like Referral with Emergency department and Intervention.
The concepts of his Physical therapy study are interwoven with issues in Quality of life and MEDLINE.
Between 2016 and 2021, his most popular works were:
- Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial (159 citations)
- Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. (143 citations)
- Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. (118 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Stroke
- Surgery
His primary areas of investigation include Stroke, Randomized controlled trial, Internal medicine, Odds ratio and Modified Rankin Scale.
His Stroke research integrates issues from Anesthesia and MEDLINE.
Gary A. Ford has included themes like Rehabilitation, Physical therapy, Adverse effect, Blood pressure and Placebo in his Randomized controlled trial study.
His research in Internal medicine intersects with topics in Magnetic resonance imaging and Cardiology.
Gary A. Ford has researched Modified Rankin Scale in several fields, including Health economics, Clinical endpoint, Surgery and Multidisciplinary approach.
He interconnects Meta-analysis, Clinical trial, Ischemic stroke and Large artery occlusion in the investigation of issues within Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
